UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 25, 2015
Medical Imaging Corp.
(Exact name of registrant as specified in charter)
| | |
NEVADA | 333-1364363 | 98-0493698 |
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
| | |
848 N. Rainbow Blvd. #2494 Las Vegas, Nevada | | 89107 |
(Address of principal executive offices) | | (Zip Code) |
Registrant’s telephone number, including area code (877) 331-3444
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12(b))
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.07 — Submission of Matters to a Vote of Security Holders
The 2015 Annual Meeting of Stockholders (the “Annual Meeting”) of Medical Imaging Corp. (the “Company”) was held on August 25, 2015.
The Company’s stockholders voted on two proposals as follows: to elect Company directors for the ensuing year (Proposal 1); and to ratify the selection by the Company’s Board of Directors of KLJ & Associates LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2015 (Proposal 2).
All nominees for election to the Board as Directors were elected to serve until the 2016 Annual Meeting of Stockholders and until their respective successors are elected and qualified, or until such director’s earlier death, resignation or removal. The stockholders ratified Proposal 2. The number of votes cast for, against or withheld and the number of abstentions and broker non-votes with respect to each Proposal is set forth below.
| | | | | | |
Proposal 1 | | Shares For | | Shares Withheld | | Broker Non-Votes |
| | | | | | |
Mitchel Geisler | | 16,072,220 | | 520,901 | | 0 |
Richard Jagodnik | | 16,072,220 | | 520.901 | | 0 |
| | | | | | | | |
| | Shares For | | Shares Against | | Shares Abstaining | | Broker Non-Votes |
| | | | | | | | |
Proposal 2 | | 17,703,910 | | 0 | | 166,667 | | 0 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | |
| Medical Imaging Corp. |
| | |
Dated: August 31, 2015 | By: | /s/ Mitchell Geisler |
| | Name: Mitchell Geisler |
| | Title: Chief Executive Officer |